<DOC>
	<DOCNO>NCT00374556</DOCNO>
	<brief_summary>This research do evaluate effect sleep pill ( eszopiclone , Lunesta ) patient arthritis knee also suffer chronic insomnia . This study test whether Lunesta improve sleep , pain sensitivity , daytime symptom patient knee pain .</brief_summary>
	<brief_title>Insomnia Osteoarthritis Study</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>Age 1864 Diagnosed physician care osteoarthritis knee accord American College Rheumatology Criteria radiographic evidence demonstrate least grade 1 OA Report least typical arthritic pain &gt; 4 10 ( 0=no pain , 10=the extreme pain imaginable ) Meet DSMIV ICSDR criterion either primary ( psychophysiologic ) insomnia insomnia secondary osteoarthritis Insomnia symptom must include problem middle night awakening Insomnia symptom duration &gt; 6 month Baseline , 2week , sleep diary average wake sleep onset time &gt; 30 minute Baseline selfreported total sleep time &lt; 6.5 hour per night Patients take NSAID therapy pain must stable dose period least one month prior initiate study Intrinsic sleep disorder insomnia ( sleep apnea , periodic limb movement disorder , etc ) Significant rheumatologic chronic pain disorder osteoarthritis knee , include fibromyalgia complaint widespread pain impact 4 quadrant , complex regional pain syndrome , post herpetic neuralgia , etc ) Major medical disease ( include , hepatic impairment , chronic obstructive pulmonary disease/compromised respiratory function , cancer , dementia , diabetes , congestive heart failure , cerebrovascular disease , raynaud 's syndrome ) Active major psychiatric disorder ( include dementia cognitive impairment ) history schizophrenia bipolar I disorder History serious suicide attempt ; 6 ) history alcohol substance ( include prescription medication ) abuse Pregnancy plan become pregnant within 6 month Intraarticular steroid injection within past month Regular ( &gt; 3 days/week ) use antidepressant , antipsychotic , mood stabilizer , within past two month Regular ( &gt; 3/week ) use myorelaxants , narcotic , sedative hypnotic , anticonvulsant within past one month Unwilling unable discontinue use medication list # 10 two week prior start study Unwilling unable discontinue centrally act agent analgesic usage within 24 hour pain test session Refusal provide consent contact patient 's physician establish diagnosis obtain medical record information Regular tobacco nicotine use Heavy caffeine use [ ( &gt; 2 cup coffee/day ( equivalent ) History previous allergic reaction severe side effect sedative hypnotic Use potent CYP3A4 inhibitor ( e.g. , ketoconazole , itraconazole , clarithromycin , troleandomycin , ritonavir , nelfinavir ) In addition , subject undergo inlaboratory blood test prior receive drug exclude participation exhibit : ) positive pregnancy test , b ) positive toxicology ( benzodiazepine , opioids , THC , alcohol , stimulant ) , c ) abnormal liver enzyme panel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>eszopiclone</keyword>
	<keyword>insomnia</keyword>
</DOC>